The B Group, Inc. 13D/13G Filings for NRx Pharmaceuticals, Inc. (NRXP)

The B Group, Inc. 13D and 13G filings for NRx Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-08-21
06:42 am
Purchase
2025-08-1813GNRx Pharmaceuticals, Inc.
NRXP
The B Group, Inc.3,000,000
12.620%
3,000,000increase
(New Position)
Filing